A recently published study by FMI expects the global fuchs endothelial corneal dystrophy (fecd) market to augment at a 7.5% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 370 Billion is expected for the market. The primary variables impacting the market growth rate include an increase …
Category Archives: Healthcare Trends
Global Advanced Therapy Medicinal Products Market is on the brink of substantial expansion, aiming for a valuation of US$ 39 Billion by 2032 | FMI
A recent analytical analysis by Future Market Insights estimates that the global Advanced Therapy Medicinal Products Market will generate US$ 8.7 billion in revenue by 2021. From 2022 to 2032, the market is projected to expand at a 15% CAGR, valued at US$ 39 billion. Tissue Engineered Products, which is estimated to grow at a …
Global Genital Warts (Condyloma Acuminatum) Market is expected to soar to US$ 3 Billion by 2033, according to the FMI Report
The genital warts (condyloma acuminatum) market is predicted to grow from its current value of US$ 1.87 billion in 2023 to US$ 3 billion by 2033, with a CAGR of 4.84%. Due to the anticipated introduction of novel medications, the dynamics of the genital warts market are anticipated to shift in the upcoming years. Drugs …
Global Scar Treatment Market, according to FMI, is expected to surge ahead to a US$ 52 billion valuation by 2032
According to a Future Market Insights analysis report, the global Scar Treatment Market had sales of US$ 13 billion in 2021. The market is anticipated to surpass US$ 52 billion by 2032, with a CAGR of 13.6% from 2022 to 2032. The market for hospitals is anticipated to generate the largest revenue and is anticipated …
Global Vernal Keratoconjunctivitis Market will hit US$ 782.42 Million by 2033, driven by the rapid increase in air pollution | FMI
The global Vernal Keratoconjunctivitis Market is expected to garner a market value of US$ 436.9 Million in 2023 and is expected to accumulate a market value of US$ 782.42 Million by registering a CAGR of 6% in the forecast period 2023 to 2033. One of the reasons driving the global market over the projection period …
Global Prostate Cancer Market is expected to witness remarkable growth, with FMI forecasting a value of US$ 24.7 Billion by 2033
The global Prostatic Cancer Market is likely to be valued at around US$ 10.92 Billion in 2023 and is projected to expand at a CAGR of 8.5% through 2033. The market is expected to reach US$ 24.7 Billion by 2033. Future Market Insights predicts that the global Prostatic Cancer Market will expand rapidly between 2023 and 2033. It is estimated that worldwide …
Global Biopsy Guidance Systems Market projected surge to US$ 2 Billion by 2032: will redefine the landscape of disease diagnosis | FMI
The global Biopsy Guidance System Market is anticipated to create an opulent growth outlook of the market over the assessment period by registering a CAGR of 5.8% from 2022 to 2032. The global market is valued at US$ 458 Million in 2022 and is expected to surpass a valuation of US$ 2 Billion by 2032. …
Global Alopecia Treatment Market is poised for rapid growth, projected to hit US$ 22.5 Billion by 2032, states a study from Future Market Insight
According to a recently published analytical report by Future Market Insight, the global alopecia treatment market has global sales of US$ 8.4 billion in 2021. The market is predicted to reach a valuation of US$ 22.5 billion by 2032 with a CAGR of 9.5% from 2022 to 2032. From 2022 to 2032, the Alopecia Treatment …
Global Primary Sclerosing Cholangitis (PSC) Market is poised to surpass US$ 314.26 Million by 2033, as projected by FMI
The global primary sclerosing cholangitis (PSC) market is expected to be worth US$ 151.07 million in 2023. Because of rising alcohol consumption, the overall demand for Primary Sclerosing Cholangitis (PSC) is expected to grow at a CAGR of 7.6% between 2023 and 2033, totaling around US$ 314.26 Million by 2033. The Primary Sclerosing Cholangitis (PSC) …
Global Amyotrophic Lateral Sclerosis Market is on a promising path, potentially achieving US$ 1332.22 Million by 2033
The global amyotrophic lateral sclerosis market is poised for significant growth, with projections indicating a compound annual growth rate (CAGR) of 6% between 2023 and 2033. A comprehensive study predicts a substantial increase from the anticipated US$ 743.90 million in 2023 to a staggering US$ 1332.22 Million by 2033. The Amyotrophic Lateral Sclerosis Market, also …